[1]
A. Yıldız, K. Okutur, and N. Eren, “Assessment of thrombin-activatable fibrinolysis inhibitor levels in essential hypertension”, Eur Res J, vol. 11, no. 1, pp. 1–10, Jan. 2025, doi: 10.18621/eurj.1501230.